var eventsData = [{"Ticker":"NLSN","EffectiveDate":"2017-02-09","Type":"EarningsRelease","Title":"Before market open, NLSN reports 2016 Q4's earning $0.44 per share and revenue $1656MM. This misses analyst's estimated EPS $0.8.","DailyReturn":"2.66%","FiveDayReturnAfter":null,"FiveDayReturnBefore":"1.77%"},{"Ticker":"NLSN","EffectiveDate":"2017-01-10","Type":"RatingNeutral","Title":"Barclays downgrades NLSN to Equal-Weight from Overweight.","DailyReturn":"-1.44%","FiveDayReturnAfter":"0.02%","FiveDayReturnBefore":"0.97%"},{"Ticker":"NLSN","EffectiveDate":"2016-12-14","Type":"RatingUpgrade","Title":"Morgan Stanley upgrades NLSN to Overweight from Equal-Weight.","DailyReturn":"2.56%","FiveDayReturnAfter":"2.93%","FiveDayReturnBefore":"-0.85%"},{"Ticker":"NLSN","EffectiveDate":"2016-12-06","Type":"RatingNeutral","Title":"Deutsche Bank initiates coverage on NLSN to Hold. Target Price is $48.","DailyReturn":"-0.02%","FiveDayReturnAfter":"-0.56%","FiveDayReturnBefore":"-2.35%"},{"Ticker":"NLSN","EffectiveDate":"2016-12-05","Type":"RatingNeutral","Title":"Barclays maintains NLSN to Overweight. Target Price is $50; previously $55.","DailyReturn":"0.8%","FiveDayReturnAfter":"1.53%","FiveDayReturnBefore":"-3.11%"},{"Ticker":"NLSN","EffectiveDate":"2016-11-18","Type":"Dividend","Title":"The Firm pays dividend $0.31","DailyReturn":"-1.77%","FiveDayReturnAfter":"-0.02%","FiveDayReturnBefore":"-2.59%"},{"Ticker":"NLSN","EffectiveDate":"2016-11-17","Type":"RatingNeutral","Title":"Citigroup assumes NLSN to Neutral. Target Price is $45.","DailyReturn":"-2.03%","FiveDayReturnAfter":"-2.75%","FiveDayReturnBefore":"-1.11%"},{"Ticker":"NLSN","EffectiveDate":"2016-11-16","Type":"RatingNeutral","Title":"SunTrust Robinson Humphrey initiates coverage on NLSN to Buy. Target Price is $50.","DailyReturn":"2.4%","FiveDayReturnAfter":"-0.83%","FiveDayReturnBefore":"-2.42%"},{"Ticker":"NLSN","EffectiveDate":"2016-11-15","Type":"RatingNeutral","Title":"SunTrust Robinson Humphrey initiates coverage on NLSN to Buy. Target Price is $50.","DailyReturn":"1.18%","FiveDayReturnAfter":"-0.4%","FiveDayReturnBefore":"-3.6%"},{"Ticker":"NLSN","EffectiveDate":"2016-10-25","Type":"EarningsRevenueMiss","Title":"Before market open, NLSN reports 2016 Q3's earning $0.74 per share and revenue $1570MM. This misses analyst's estimated EPS $0.76, misses estimated revenue $1590MM.","DailyReturn":"-16.89%","FiveDayReturnAfter":"-19.89%","FiveDayReturnBefore":"2.69%"},{"Ticker":"NLSN","EffectiveDate":"2016-09-15","Type":"RatingNeutral","Title":"Cantor Fitzgerald initiates coverage on NLSN to Hold.","DailyReturn":"1.25%","FiveDayReturnAfter":"0.88%","FiveDayReturnBefore":"-2.85%"},{"Ticker":"NLSN","EffectiveDate":"2016-08-25","Type":"RatingNeutral","Title":"Macquarie initiates coverage on NLSN to Outperform. Target Price is $61.","DailyReturn":"0.22%","FiveDayReturnAfter":"1.51%","FiveDayReturnBefore":"-0.49%"},{"Ticker":"NLSN","EffectiveDate":"2016-08-23","Type":"Dividend","Title":"The Firm pays dividend $0.31","DailyReturn":"-0.5%","FiveDayReturnAfter":"-0.92%","FiveDayReturnBefore":"1.01%"},{"Ticker":"NLSN","EffectiveDate":"2016-07-27","Type":"RatingNeutral","Title":"JP Morgan maintains NLSN to Overweight. Target Price is $64; previously $60.","DailyReturn":"-0.25%","FiveDayReturnAfter":"-1.84%","FiveDayReturnBefore":"-0.35%"},{"Ticker":"NLSN","EffectiveDate":"2016-07-26","Type":"RevenueBeat","Title":"Before market open, NLSN reports 2016 Q2's earning $0.71 per share and revenue $1596MM. This meets analyst's estimated EPS $0.71, misses estimated revenue $1610MM.","DailyReturn":"-1.86%","FiveDayReturnAfter":"-3.18%","FiveDayReturnBefore":"2.17%"},{"Ticker":"NLSN","EffectiveDate":"2016-07-22","Type":"RatingNeutral","Title":"BMO Capital downgrades NLSN to Market Perform from Outperform.","DailyReturn":"0.7%","FiveDayReturnAfter":"-2.31%","FiveDayReturnBefore":"2.54%"},{"Ticker":"NLSN","EffectiveDate":"2016-05-31","Type":"Dividend","Title":"The Firm pays dividend $0.31","DailyReturn":"-0.03%","FiveDayReturnAfter":"1.65%","FiveDayReturnBefore":"2.87%"},{"Ticker":"NLSN","EffectiveDate":"2016-04-20","Type":"EarningsBeatRevenueMiss","Title":"Before market open, NLSN reports 2016 Q1's earning $0.51 per share and revenue $1487MM. This beats analyst's estimated EPS $0.5, misses estimated revenue $1490MM.","DailyReturn":"-2.03%","FiveDayReturnAfter":"-3.73%","FiveDayReturnBefore":"1.98%"},{"Ticker":"NLSN","EffectiveDate":"2016-04-07","Type":"RatingNeutral","Title":"Citigroup maintains NLSN to Buy. Target Price is $59; previously $52.","DailyReturn":"-0.62%","FiveDayReturnAfter":"1.07%","FiveDayReturnBefore":"-0.34%"},{"Ticker":"NLSN","EffectiveDate":"2016-03-22","Type":"RatingNeutral","Title":"Sterne Agee CRT initiates coverage on NLSN to Buy.","DailyReturn":"-0.4%","FiveDayReturnAfter":"0.7%","FiveDayReturnBefore":"1.9%"},{"Ticker":"NLSN","EffectiveDate":"2016-03-09","Type":"RatingNeutral","Title":"Morgan Stanley downgrades NLSN to Equal-Weight from Overweight. Target Price is $52.","DailyReturn":"-0.93%","FiveDayReturnAfter":"-0.11%","FiveDayReturnBefore":"1.02%"},{"Ticker":"NLSN","EffectiveDate":"2016-03-01","Type":"Dividend","Title":"The Firm pays dividend $0.28","DailyReturn":"1.07%","FiveDayReturnAfter":"3.53%","FiveDayReturnBefore":"1.78%"},{"Ticker":"NLSN","EffectiveDate":"2016-02-29","Type":"RatingNeutral","Title":"Jefferies initiates coverage on NLSN to Buy. Target Price is $58.","DailyReturn":"1.18%","FiveDayReturnAfter":"4.46%","FiveDayReturnBefore":"3.39%"},{"Ticker":"NLSN","EffectiveDate":"2016-02-12","Type":"RatingNeutral","Title":"Deutsche Bank maintains NLSN to Buy. Target Price is $51; previously $50.","DailyReturn":"-0.08%","FiveDayReturnAfter":"1.59%","FiveDayReturnBefore":"1.33%"},{"Ticker":"NLSN","EffectiveDate":"2015-11-20","Type":"Dividend","Title":"The Firm pays dividend $0.28","DailyReturn":"0.67%","FiveDayReturnAfter":"-0.61%","FiveDayReturnBefore":"1.03%"},{"Ticker":"NLSN","EffectiveDate":"2015-09-02","Type":"RatingNeutral","Title":"Bernstein maintains NLSN to Outperform. Target Price is $55; previously $54.","DailyReturn":"4.13%","FiveDayReturnAfter":"5.92%","FiveDayReturnBefore":"1.78%"},{"Ticker":"NLSN","EffectiveDate":"2015-08-25","Type":"Dividend","Title":"The Firm pays dividend $0.28","DailyReturn":"-1.31%","FiveDayReturnAfter":"4.19%","FiveDayReturnBefore":"-10.24%"},{"Ticker":"NLSN","EffectiveDate":"2015-08-10","Type":"RatingUpgrade","Title":"BMO Capital upgrades NLSN to Outperform from Market Perform. Target Price is $53; previously $46.","DailyReturn":"3.33%","FiveDayReturnAfter":"4.33%","FiveDayReturnBefore":"-4.23%"},{"Ticker":"NLSN","EffectiveDate":"2015-07-29","Type":"RatingNeutral","Title":"Barclays maintains NLSN to Overweight. Target Price is $53; previously $50.","DailyReturn":"2.41%","FiveDayReturnAfter":"1.61%","FiveDayReturnBefore":"4%"},{"Ticker":"NLSN","EffectiveDate":"2015-07-29","Type":"RatingNeutral","Title":"Deutsche Bank maintains NLSN to Buy. Target Price is $48; previously $47.","DailyReturn":"2.41%","FiveDayReturnAfter":"1.61%","FiveDayReturnBefore":"4%"},{"Ticker":"NLSN","EffectiveDate":"2015-06-02","Type":"Dividend","Title":"The Firm pays dividend $0.28","DailyReturn":"0.38%","FiveDayReturnAfter":"-0.56%","FiveDayReturnBefore":"-2.22%"},{"Ticker":"NLSN","EffectiveDate":"2015-04-23","Type":"RatingNeutral","Title":"Deutsche Bank maintains NLSN to Buy. Target Price is $47; previously $46.","DailyReturn":"0.45%","FiveDayReturnAfter":"-1.48%","FiveDayReturnBefore":"1.48%"},{"Ticker":"NLSN","EffectiveDate":"2015-04-13","Type":"RatingNeutral","Title":"Pivotal Research downgrades NLSN to Hold from Buy. Target Price is $49.","DailyReturn":"-1.1%","FiveDayReturnAfter":"-3.99%","FiveDayReturnBefore":"1.04%"},{"Ticker":"NLSN","EffectiveDate":"2015-04-09","Type":"RatingNeutral","Title":"Telsey Advisory Group initiates coverage on NLSN to Outperform. Target Price is $53.","DailyReturn":"0.46%","FiveDayReturnAfter":"-0.41%","FiveDayReturnBefore":"2.3%"},{"Ticker":"NLSN","EffectiveDate":"2015-03-03","Type":"Dividend","Title":"The Firm pays dividend $0.25","DailyReturn":"0.29%","FiveDayReturnAfter":"-1.23%","FiveDayReturnBefore":"-1.5%"},{"Ticker":"NLSN","EffectiveDate":"2015-02-13","Type":"RatingNeutral","Title":"Citigroup maintains NLSN to Buy. Target Price is $49; previously $50.","DailyReturn":"4.63%","FiveDayReturnAfter":"3.84%","FiveDayReturnBefore":"-0.93%"},{"Ticker":"NLSN","EffectiveDate":"2015-02-06","Type":"RatingNeutral","Title":"Deutsche Bank maintains NLSN to Buy. Target Price is $46; previously $47.","DailyReturn":"-1.13%","FiveDayReturnAfter":"-0.93%","FiveDayReturnBefore":"-0.81%"},{"Ticker":"NLSN","EffectiveDate":"2015-02-06","Type":"RatingNeutral","Title":"Citigroup maintains NLSN to Buy. Target Price is $50; previously $51.","DailyReturn":"-1.13%","FiveDayReturnAfter":"-0.93%","FiveDayReturnBefore":"-0.81%"},{"Ticker":"NLSN","EffectiveDate":"2014-12-11","Type":"RatingNeutral","Title":"Credit Suisse maintains NLSN to Outperform. Target Price is $52; previously $56.","DailyReturn":"-1.62%","FiveDayReturnAfter":"0.06%","FiveDayReturnBefore":"0.02%"},{"Ticker":"NLSN","EffectiveDate":"2014-12-10","Type":"RatingNeutral","Title":"Morgan Stanley maintains NLSN to Overweight. Target Price is $53; previously $52.","DailyReturn":"-3.09%","FiveDayReturnAfter":"-3.79%","FiveDayReturnBefore":"7.89%"},{"Ticker":"NLSN","EffectiveDate":"2014-11-21","Type":"Dividend","Title":"The Firm pays dividend $0.25","DailyReturn":"0.34%","FiveDayReturnAfter":"1.81%","FiveDayReturnBefore":"-2.7%"},{"Ticker":"NLSN","EffectiveDate":"2014-10-27","Type":"RatingNeutral","Title":"Barclays maintains NLSN to Overweight. Target Price is $50; previously $55.","DailyReturn":"-0.28%","FiveDayReturnAfter":"0.44%","FiveDayReturnBefore":"0.64%"},{"Ticker":"NLSN","EffectiveDate":"2014-10-24","Type":"RatingNeutral","Title":"Citigroup maintains NLSN to Buy. Target Price is $48; previously $52.","DailyReturn":"1.14%","FiveDayReturnAfter":"-1%","FiveDayReturnBefore":"0.55%"},{"Ticker":"NLSN","EffectiveDate":"2014-10-20","Type":"RatingNeutral","Title":"Deutsche Bank maintains NLSN to Buy. Target Price is $46; previously $50.","DailyReturn":"0.28%","FiveDayReturnAfter":"0.64%","FiveDayReturnBefore":"0.78%"},{"Ticker":"NLSN","EffectiveDate":"2014-10-14","Type":"RatingUpgrade","Title":"Bernstein upgrades NLSN to Outperform from Market Perform. Target Price is $49; previously $51.","DailyReturn":"0.64%","FiveDayReturnAfter":"0.71%","FiveDayReturnBefore":"-2.52%"},{"Ticker":"NLSN","EffectiveDate":"2014-10-10","Type":"RatingUpgrade","Title":"Pivotal Research upgrades NLSN to Buy from Hold. Target Price is $50; previously $48.","DailyReturn":"0.99%","FiveDayReturnAfter":"0.72%","FiveDayReturnBefore":"-5.71%"},{"Ticker":"NLSN","EffectiveDate":"2014-08-26","Type":"Dividend","Title":"The Firm pays dividend $0.25","DailyReturn":"-0.46%","FiveDayReturnAfter":"-0.78%","FiveDayReturnBefore":"-1.61%"},{"Ticker":"NLSN","EffectiveDate":"2014-07-17","Type":"RatingNeutral","Title":"Pivotal Research downgrades NLSN to Hold from Buy.","DailyReturn":"-1.5%","FiveDayReturnAfter":"-0.35%","FiveDayReturnBefore":"-0.75%"},{"Ticker":"NLSN","EffectiveDate":"2014-06-19","Type":"RatingNeutral","Title":"JP Morgan maintains NLSN to Overweight. Target Price is $53; previously $51.","DailyReturn":"0.4%","FiveDayReturnAfter":"1.88%","FiveDayReturnBefore":"0.27%"},{"Ticker":"NLSN","EffectiveDate":"2014-06-03","Type":"Dividend","Title":"The Firm pays dividend $0.25","DailyReturn":"-1.3%","FiveDayReturnAfter":"-0.16%","FiveDayReturnBefore":"0.71%"},{"Ticker":"NLSN","EffectiveDate":"2014-05-14","Type":"RatingNeutral","Title":"Barclays initiates coverage on NLSN to Overweight. Target Price is $55.","DailyReturn":"-0.04%","FiveDayReturnAfter":"-0.72%","FiveDayReturnBefore":"0.55%"},{"Ticker":"NLSN","EffectiveDate":"2014-04-25","Type":"RatingNeutral","Title":"Deutsche Bank maintains NLSN to Buy. Target Price is $50; previously $48.","DailyReturn":"-0.15%","FiveDayReturnAfter":"2.4%","FiveDayReturnBefore":"4.18%"},{"Ticker":"NLSN","EffectiveDate":"2014-04-25","Type":"RatingNeutral","Title":"JP Morgan maintains NLSN to Overweight. Target Price is $51; previously $49.","DailyReturn":"-0.15%","FiveDayReturnAfter":"2.4%","FiveDayReturnBefore":"4.18%"},{"Ticker":"NLSN","EffectiveDate":"2014-03-04","Type":"Dividend","Title":"The Firm pays dividend $0.2","DailyReturn":"1.44%","FiveDayReturnAfter":"-0.08%","FiveDayReturnBefore":"-0.47%"},{"Ticker":"NLSN","EffectiveDate":"2014-02-21","Type":"RatingNeutral","Title":"Baird initiates coverage on NLSN to Neutral. Target Price is $50.","DailyReturn":"-0.19%","FiveDayReturnAfter":"0.9%","FiveDayReturnBefore":"1.65%"},{"Ticker":"NLSN","EffectiveDate":"2014-02-20","Type":"RatingNeutral","Title":"Baird initiates coverage on NLSN to Neutral. Target Price is $50.","DailyReturn":"0.04%","FiveDayReturnAfter":"0.04%","FiveDayReturnBefore":"3.02%"},{"Ticker":"NLSN","EffectiveDate":"2014-02-13","Type":"RatingNeutral","Title":"Wells Fargo initiates coverage on NLSN to Outperform.","DailyReturn":"-0.81%","FiveDayReturnAfter":"1.65%","FiveDayReturnBefore":"7.17%"},{"Ticker":"NLSN","EffectiveDate":"2014-02-13","Type":"EarningsBeatRevenueMiss","Title":"Before market open, NLSN reports 2013 Q4's earning $0.71 per share and revenue $1610MM. This beats analyst's estimated EPS $0.7, misses estimated revenue $1620MM.","DailyReturn":"-0.81%","FiveDayReturnAfter":"1.65%","FiveDayReturnBefore":"7.17%"},{"Ticker":"NLSN","EffectiveDate":"2014-02-06","Type":"RatingNeutral","Title":"Deutsche Bank assumes NLSN to Buy. Target Price is $48.","DailyReturn":"2.37%","FiveDayReturnAfter":"7.17%","FiveDayReturnBefore":"0.68%"},{"Ticker":"NLSN","EffectiveDate":"2014-02-04","Type":"RatingUpgrade","Title":"Pivotal Research upgrades NLSN to Buy from Hold. Target Price is $48.","DailyReturn":"2.6%","FiveDayReturnAfter":"9.5%","FiveDayReturnBefore":"-4.1%"},{"Ticker":"NLSN","EffectiveDate":"2013-12-16","Type":"RatingNeutral","Title":"BMO Capital downgrades NLSN to Market Perform from Outperform. Target Price is $45; previously $43.","DailyReturn":"0%","FiveDayReturnAfter":"-0.59%","FiveDayReturnBefore":"4.64%"},{"Ticker":"NLSN","EffectiveDate":"2013-12-13","Type":"RatingNeutral","Title":"Citigroup maintains NLSN to Buy. Target Price is $49; previously $42.","DailyReturn":"6.19%","FiveDayReturnAfter":"4.92%","FiveDayReturnBefore":"0.6%"},{"Ticker":"NLSN","EffectiveDate":"2013-12-11","Type":"RatingNeutral","Title":"Credit Suisse initiates coverage on NLSN to Outperform. Target Price is $52.","DailyReturn":"-0.29%","FiveDayReturnAfter":"3.88%","FiveDayReturnBefore":"1.74%"},{"Ticker":"NLSN","EffectiveDate":"2013-11-21","Type":"Dividend","Title":"The Firm pays dividend $0.2","DailyReturn":"-0.19%","FiveDayReturnAfter":"6.34%","FiveDayReturnBefore":"0.74%"},{"Ticker":"NLSN","EffectiveDate":"2013-10-29","Type":"RatingNeutral","Title":"FBR Capital initiates coverage on NLSN to Outperform. Target Price is $44.","DailyReturn":"1.43%","FiveDayReturnAfter":"2.23%","FiveDayReturnBefore":"0.66%"},{"Ticker":"NLSN","EffectiveDate":"2013-10-24","Type":"RatingNeutral","Title":"Deutsche Bank maintains NLSN to Buy. Target Price is $41; previously $40.","DailyReturn":"1.8%","FiveDayReturnAfter":"2.06%","FiveDayReturnBefore":"2.99%"},{"Ticker":"NLSN","EffectiveDate":"2013-10-01","Type":"RatingNeutral","Title":"JP Morgan assumes NLSN to Overweight. Target Price is $43.","DailyReturn":"1.86%","FiveDayReturnAfter":"-0.66%","FiveDayReturnBefore":"0.19%"},{"Ticker":"NLSN","EffectiveDate":"2013-09-20","Type":"RatingNeutral","Title":"Goldman Sachs assumes NLSN to Neutral. Target Price is $38.","DailyReturn":"-3.52%","FiveDayReturnAfter":"-1.79%","FiveDayReturnBefore":"4.2%"},{"Ticker":"NLSN","EffectiveDate":"2013-09-20","Type":"RatingNeutral","Title":"Bernstein downgrades NLSN to Market Perform from Outperform. Target Price is $40; previously $38.","DailyReturn":"-3.52%","FiveDayReturnAfter":"-1.79%","FiveDayReturnBefore":"4.2%"},{"Ticker":"NLSN","EffectiveDate":"2013-08-26","Type":"Dividend","Title":"The Firm pays dividend $0.2","DailyReturn":"1.32%","FiveDayReturnAfter":"1.87%","FiveDayReturnBefore":"3.98%"},{"Ticker":"NLSN","EffectiveDate":"2013-08-20","Type":"RatingUpgrade","Title":"Bernstein upgrades NLSN to Outperform from Market Perform.","DailyReturn":"3.41%","FiveDayReturnAfter":"5.85%","FiveDayReturnBefore":"-2.63%"},{"Ticker":"NLSN","EffectiveDate":"2013-06-03","Type":"Dividend","Title":"The Firm pays dividend $0.16","DailyReturn":"0.77%","FiveDayReturnAfter":"1.47%","FiveDayReturnBefore":"-1.66%"},{"Ticker":"NLSN","EffectiveDate":"2013-04-29","Type":"RatingNeutral","Title":"Northland Securities initiates coverage on NLSN to Underperform. Target Price is $28.","DailyReturn":"-1.46%","FiveDayReturnAfter":"2.55%","FiveDayReturnBefore":"-0.6%"},{"Ticker":"NLSN","EffectiveDate":"2013-04-25","Type":"EarningsBeatRevenueMiss","Title":"Before market open, NLSN reports 2013 Q1's earning $0.38 per share and revenue $1380MM. This beats analyst's estimated EPS $0.36, misses estimated revenue $1400MM.","DailyReturn":"0.75%","FiveDayReturnAfter":"2.72%","FiveDayReturnBefore":"-1.67%"},{"Ticker":"NLSN","EffectiveDate":"2013-04-19","Type":"RatingNeutral","Title":"BMO Capital initiates coverage on NLSN to Outperform. Target Price is $41.","DailyReturn":"0.66%","FiveDayReturnAfter":"-0.25%","FiveDayReturnBefore":"-3.17%"},{"Ticker":"NLSN","EffectiveDate":"2013-03-04","Type":"Dividend","Title":"The Firm pays dividend $0.16","DailyReturn":"0.05%","FiveDayReturnAfter":"2.9%","FiveDayReturnBefore":"5.4%"},{"Ticker":"NLSN","EffectiveDate":"2013-02-15","Type":"RatingNeutral","Title":"Benchmark maintains NLSN to Buy. Target Price is $38; previously $36.","DailyReturn":"-0.46%","FiveDayReturnAfter":"-0.89%","FiveDayReturnBefore":"-0.49%"},{"Ticker":"NLSN","EffectiveDate":"2013-02-12","Type":"RatingNeutral","Title":"Citigroup maintains NLSN to Buy. Target Price is $38; previously $35.","DailyReturn":"1.8%","FiveDayReturnAfter":"0.06%","FiveDayReturnBefore":"2.16%"},{"Ticker":"NLSN","EffectiveDate":"2013-02-12","Type":"RatingNeutral","Title":"Credit Suisse maintains NLSN to Outperform. Target Price is $38; previously $35.","DailyReturn":"1.8%","FiveDayReturnAfter":"0.06%","FiveDayReturnBefore":"2.16%"},{"Ticker":"NLSN","EffectiveDate":"2013-02-11","Type":"EarningsBeatRevenueMiss","Title":"After market close, NLSN reports 2012 Q4's earning $0.62 per share and revenue $1460MM. This beats analyst's estimated EPS $0.59, misses estimated revenue $1480MM.","DailyReturn":"-0.42%","FiveDayReturnAfter":"-1.25%","FiveDayReturnBefore":"0.82%"},{"Ticker":"NLSN","EffectiveDate":"2013-01-07","Type":"RatingNeutral","Title":"Pivotal Research maintains NLSN to Hold. Target Price is $33; previously $31.","DailyReturn":"1.15%","FiveDayReturnAfter":"-0.09%","FiveDayReturnBefore":"2.86%"},{"Ticker":"NLSN","EffectiveDate":"2012-12-19","Type":"RatingNeutral","Title":"Deutsche Bank maintains NLSN to Buy. Target Price is $41; previously $36.","DailyReturn":"-1.22%","FiveDayReturnAfter":"-1.82%","FiveDayReturnBefore":"5%"},{"Ticker":"NLSN","EffectiveDate":"2012-11-28","Type":"RatingNeutral","Title":"Pivotal Research initiates coverage on NLSN. Target Price is $31.","DailyReturn":"0.39%","FiveDayReturnAfter":"1.48%","FiveDayReturnBefore":"1.36%"},{"Ticker":"NLSN","EffectiveDate":"2012-10-23","Type":"RatingNeutral","Title":"Deutsche Bank maintains NLSN to Buy. Target Price is $36; previously $35.","DailyReturn":"-2.12%","FiveDayReturnAfter":"-2.49%","FiveDayReturnBefore":"-4.29%"},{"Ticker":"NLSN","EffectiveDate":"2012-10-22","Type":"EarningsRelease","Title":"Before market open, NLSN reports 2012 Q3's earning $0.29 per share and revenue $1351MM..","DailyReturn":"-5.72%","FiveDayReturnAfter":"-8.38%","FiveDayReturnBefore":"2.18%"},{"Ticker":"NLSN","EffectiveDate":"2012-10-10","Type":"RatingNeutral","Title":"Goldman Sachs maintains NLSN to Buy. Target Price is $36; previously $35.","DailyReturn":"0.56%","FiveDayReturnAfter":"4.3%","FiveDayReturnBefore":"0.16%"},{"Ticker":"NLSN","EffectiveDate":"2012-08-09","Type":"RatingNeutral","Title":"Goldman Sachs maintains NLSN to Buy. Target Price is $35; previously $33.","DailyReturn":"1.32%","FiveDayReturnAfter":"-0.1%","FiveDayReturnBefore":"0.35%"},{"Ticker":"NLSN","EffectiveDate":"2012-07-25","Type":"EarningsBeatRevenueMiss","Title":"Before market open, NLSN reports 2012 Q2's earning $0.42 per share and revenue $1390MM. This beats analyst's estimated EPS $0.41, misses estimated revenue $1400MM.","DailyReturn":"9.98%","FiveDayReturnAfter":"12.98%","FiveDayReturnBefore":"-3.99%"},{"Ticker":"NLSN","EffectiveDate":"2012-07-18","Type":"RatingNeutral","Title":"PiperJaffray maintains NLSN to Neutral. Target Price is $26; previously $28.","DailyReturn":"-0.3%","FiveDayReturnAfter":"-3.99%","FiveDayReturnBefore":"-1.14%"},{"Ticker":"NLSN","EffectiveDate":"2012-04-25","Type":"EarningsRelease","Title":"Before market open, NLSN reports 2012 Q1's earning $0.07 per share and revenue $1334MM..","DailyReturn":"-0.34%","FiveDayReturnAfter":"-0.51%","FiveDayReturnBefore":"0.47%"},{"Ticker":"NLSN","EffectiveDate":"2012-03-21","Type":"RatingNeutral","Title":"JP Morgan maintains NLSN to Overweight. Target Price is $37; previously $34.","DailyReturn":"-0.42%","FiveDayReturnAfter":"-1.08%","FiveDayReturnBefore":"2.81%"}];